Posted: Oct 26, 2012 9:39 PM by Associated Press
ATLANTA (AP) - Federal authorities say they are working with Tennessee officials to investigate why at least 12 patients in that state who injected the pain reliever Opana ER for non-medical reasons since February have a rare blood disorder.
The Centers for Disease Control and Prevention issued the health advisory Friday night regarding the pain reliever, an extended-release form of oxymorphone. The CDC is working with the Food and Drug Administration and the Tennessee Department of Health.
The investigation is focusing on a cluster of patients with Thrombotic Thrombocytopenic Purpura, described by officials as a blood disorder in which clots form in small blood vessels throughout the body. It is an uncommon but serious illness.
Authorities say Opana ER is only supposed to be taken orally. The cases were reported in Tennessee from April 16 to Oct. 19. Most of the women did not have a prescription and reported a history of chronic IV use of the opioid pain reliever for nonmedical reasons. All of the women were hospitalized, but no deaths have occurred.
Click here to submit a news tip to us!
Become a Facebook Fan!
Help those in need this holiday season
Win! Win! Win!
Wise Local Marketing!
Get news, weather and more on your smartphone and tablet!
Get texts for news, traffic, deals and more!
Sign up on KVOA.com for newsletters, exclusive deals, and more!
What's happening on News 4 @ 4
Stories and videos with Kristi's Kids
Check out the latest events FC Tucson has scheduled.
Let us help grow your business
Digital Channel 4.2
What's on KVOA and when!
Contact info for our department heads
KVOA's on air personalities!
Work at News 4 Tucson
Complete feeds of all KVOA.com stories
FCC Public File of Records, Reports, and More